Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Pravastatin and fenofibrate in combination (Pravafenix(®)) for the treatment of high-risk patients with mixed hyperlipidemia.

Farnier M.

Expert Rev Cardiovasc Ther. 2012 May;10(5):565-75. doi: 10.1586/erc.12.37. Review. Erratum in: Expert Rev Cardiovasc Ther. 2013 Feb;11(2):253-4.

PMID:
22651832
2.

[Combination of pravastatin and fenofibrate (Pravafenix ®). Safety studies].

Hernández Mijares A.

Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:25-30. doi: 10.1016/S0214-9168(14)70023-3. Review. Spanish.

PMID:
25043544
3.

[Efficacy studies].

Pedro-Botet J, Flores-Le Roux JA.

Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:17-9. doi: 10.1016/S0214-9168(14)70021-X. Spanish.

PMID:
25043542
4.

Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy.

Farnier M, Ducobu J, Bryniarski L.

Curr Med Res Opin. 2011 Nov;27(11):2165-73. doi: 10.1185/03007995.2011.626398. Epub 2011 Oct 5.

PMID:
21973199
6.

[The fixed combination of pravastatin and fenofibrate: what can it provide?].

Díaz Rodríguez Á.

Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:12-6. doi: 10.1016/S0214-9168(14)70020-8. Spanish.

PMID:
25043541
7.

Efficacy and safety of adding fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by pravastatin 40 mg monotherapy.

Farnier M, Ducobu J, Bryniarski L.

Am J Cardiol. 2010 Sep 15;106(6):787-92. doi: 10.1016/j.amjcard.2010.05.005. Epub 2010 Aug 2.

PMID:
20816118
8.

[Indications for the combination of pravastatin and fenofibrate according to the type of dyslipidemia].

Núñez-Cortés JM.

Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:31-4. doi: 10.1016/S0214-9168(14)70024-5. Spanish.

PMID:
25043545
9.

Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials.

Farnier M, Marcereuil D, De Niet S, Ducobu J, Steinmetz A, Retterstøl K, Bryniarski L, Császár A, Vanderbist F.

Clin Drug Investig. 2012 Apr 1;32(4):281-91. doi: 10.2165/11630820-000000000-00000.

PMID:
22350498
10.

Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease.

Farnier M, Retterstøl K, Steinmetz A, Császár A.

Diab Vasc Dis Res. 2012 Jul;9(3):205-15. doi: 10.1177/1479164111430715. Epub 2012 Jan 6.

PMID:
22228773
11.

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.

Ellen RL, McPherson R.

Am J Cardiol. 1998 Feb 26;81(4A):60B-65B. Review.

PMID:
9526816
12.

[Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].

Kłosiewicz-Latoszek L, Respondek W, Białobrzeska-Paluszkiewicz J, Grzybowska B, Jakóbisiak-Ostasz B, Stolarska I.

Pol Merkur Lekarski. 2003 Jul;15(85):42-6. Polish.

PMID:
14593958
13.

Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.

Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.

Kardiol Pol. 2004 Jun;60(6):567-77. English, Polish.

PMID:
15334157
14.

A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients.

Lemieux I, Laperrière L, Dzavik V, Tremblay G, Bourgeois J, Després JP.

Atherosclerosis. 2002 Jun;162(2):363-71.

PMID:
11996956
15.

Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia.

Filippatos TD, Elisaf MS.

Expert Opin Pharmacother. 2011 Aug;12(12):1945-58. doi: 10.1517/14656566.2011.593509. Epub 2011 Jul 8. Review.

PMID:
21736529
16.

Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.

Keating GM.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):227-47. doi: 10.2165/11207690-000000000-00000. Review.

PMID:
21675801
17.

Micronized fenofibrate: a new fibric acid hypolipidemic agent.

Guay DR.

Ann Pharmacother. 1999 Oct;33(10):1083-103. Review.

PMID:
10534222
18.
19.
20.

[Efficacy and safety of combination therapy with simvastatin and fenofibrate for combined hyperlipidemia].

Ren JY, Chen H, Luo Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Feb;33(2):122-6. Chinese.

PMID:
15924805

Supplemental Content

Support Center